Furthermore, CRYBB1, CEACAM4, and HAMP could serve as prognostic biomarkers or potential drug targets for ccRCC, especially for the combination with sunitinib. The gene discussed is CRYBB1; the disease is nonpapillary renal cell carcinoma.